Metabolic Syndrome and Glucose Control Panel
The Metabolic Syndrome & Glucose Control Panel evaluates key biomarkers—fasting glucose, insulin, lipids, and related metrics—to assess insulin resistance, glucose dysregulation, and cardiometabolic risk. This integrated panel helps clinicians identify metabolic syndrome early, monitor glycemic control, and guide interventions to reduce progression to type 2 diabetes and cardiovascular disease.
- $199.69
- $188.95
- Save: 5.38%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Chol/HDLC Ratio
Cholesterol, Total
Glucose
Glucose
HDL Cholesterol
INSULIN, INTACT, LC/MS/MS
Insulin, LC/MS/MS
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
The Metabolic Syndrome and Glucose Control Panel test contains 1 test with 10 biomarkers .
Identifying patients who have metabolic syndrome and who are thus at higher risk of diabetes, coronary heart disease or stroke. Identifying patients who are insulin resistant (fasting insulin at or above the 75th percentile) and who are thus at higher risk of diabetes, coronary heart disease, stroke, or liver disease. Monitoring of risk factors and insulin levels after life style change, medication use, or both.